Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue

Go back to Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 45.14 +0.66 (1.48%)
Previous Close $44.48    52 Week High $26.84 
Open $44.55    52 Week Low $9.51 
Day High $45.50    P/E N/A 
Day Low $44.12    EPS $-2.62 
Volume 759,698